(Press-News.org) Genome editing-based therapies typically aim to treat disease by correcting underlying genetic mutations in patient’s cells. However, most genetic disorders are caused by dozens or even thousands of unique mutations spread across a gene; this diversity results in challenges of scale when it comes to developing customized therapies for many individuals. A more universal strategy could involve the precise insertion of an entire copy of a healthy gene into a specific location in the genome, which could, in principle, provide a single, widely applicable treatment for all patients irrespective of their mutation within that gene.
Taking a step towards developing genetic therapies at scale, researchers from Mass General Brigham and colleagues describe a novel, non-toxic approach for inserting gene-sized DNA in a study published in Nature.
“Overall, this study demonstrates that large-scale genome writing is now possible without triggering dangerous immune responses and can be done independently of viral vectors,” said senior author Benjamin P. Kleinstiver, PhD, Kayden-Lambert MGH Research Scholar associate investigator in the Center for Genomic Medicine at Mass General Brigham. “With this approach, we may be able to move beyond the treatment of single mutations at a time. Our goal is to improve the systems we’ve developed in ways that can broaden their applicability to genetic treatments.”
Most approaches to insert large corrective DNA sequences into the genome utilize recombinase enzymes that rely on double-stranded DNA (dsDNA) molecules carrying the intended DNA cargo, which can trigger strong immune reactions that cause toxicity and ultimately limits how much treatment can be given, especially when therapies are delivered directly into the body. Although viruses can act as vectors to shuttle the DNA cargo into the nucleus, their use is subject to several caveats in terms of cost, safety, and other factors. Developing a virus-free targeted DNA integration method has therefore been a long-standing goal for the genome editing field.
The team recognized that circles comprised of only single DNA strands were largely able to evade immune detection. However, this apparent solution resulted in a different problem: recombinase enzymes evolved to recognize DNA molecules with two strands, making them incompatible with single-stranded DNA.
The team then investigated ways that natural systems had overcome similar problems, and realized that bacteria and bacteriophages had developed tricks to insert single-stranded DNA into a dsDNA host genome using recombinases.
“This was an exciting realization,” said lead author Connor Tou, PhD, a postdoctoral fellow in the Kleinstiver lab. “We then wondered whether these mechanisms could be recapitulated in human cells, hoping to solve the innate immunity challenge that has impeded efficient gene insertion.”
The team designed a different configuration using a DNA circle comprised largely of only a single strand that could remain ‘stealth’ to innate immune sensors, and a short region of two DNA strands to enable compatibility with recombinases. This dsDNA region could be designed to be long enough to allow the recombinase to function, but short enough to avoid immune detection.
The team then demonstrated that their new approach, called INSTALL, could enable non-toxic DNA integration in multiple human cell types. Furthermore, when performing in vivo experiments in mice by delivering the DNA via lipid nanoparticles (LNPs), INSTALL could successfully and safely insert large genetic payloads in the livers of mice, compared to fatal immune reactions observed when conventional dsDNA molecules were used.
"One of the most exciting moments of this study was seeing the stark differences in how well the mice responded to INSTALL compared with the toxicity of dsDNA," Tou noted. "When the INSTALL-treated mice looked similar to untreated controls, we knew this could be a game changer."
The authors are optimistic that continued efforts to improve the DNA cargo, alongside recombinase enzyme engineering, will result in substantial advances in large sequence insertion technologies in the near future.
Authorship: This study was a large collaborative effort, with key intellectual and experimental contributions from Howard Wu and Keqiang Xie, of Full Circles Therapeutics, a company that manufactures and commercializes circular single stranded DNA, as well as developing DNA based non-viral genomic medicines. The laboratory of Patricia Musolino of the Mass General Brigham Center for Genomic Medicine helped to lead DNA integration and immunology studies in mice. The laboratory of Natalie Artzi at the Mass General Brigham Gene and Cell Therapy Institute and the Wyss Institute for Biologically Inspired Engineering led the design and formulation of LNPs for delivery of mRNA and DNA cargos and contributed to the development and execution of the immune profiling strategy for the platform. Additional authors include Joana Ferreira da Silva, Pazhanichamy Kalailingam, Eliz Amar-Lewis, David Rufino-Ramos, William Sawyer, Madeline L. Eller, Jakob Starzy, Ishita Majumdar, Jiao Wang, Danna Lee, Shaobo Yang, Ronald J. Meis, Gary A. Dahl, Jiahe Li, and Richard Shan.
Paper cited: Tou C et al. “Immune evasive DNA donors and recombinases license kilobase-scale writing” Nature DOI: 10.1038/s41586-026-10241-z
###
About Mass General Brigham
Mass General Brigham is an integrated academic health care system, uniting great minds to solve the hardest problems in medicine for our communities and the world. Mass General Brigham connects a full continuum of care across a system of academic medical centers, community and specialty hospitals, a health insurance plan, physician networks, community health centers, home care, and long-term care services. Mass General Brigham is a nonprofit organization committed to patient care, research, teaching, and service to the community. In addition, Mass General Brigham is one of the nation’s leading biomedical research organizations with several Harvard Medical School teaching hospitals. For more information, please visit massgeneralbrigham.org.
END
Astronomers have for the first time seen the birth of a magnetar — a highly magnetized, spinning neutron star — and confirmed that it’s the power source behind some of the brightest exploding stars in the cosmos.
The finding corroborates a theory proposed by a UC Berkeley physicist 16 years ago and establishes a new phenomenon in exploding stars: supernovae with a “chirp” in their light curve that is caused by general relativity. A paper describing the phenomenon was published today ...
CAMBRIDGE, MA -- Photonic chips use light to process data instead of electricity, enabling faster communication speeds and greater bandwidth. Most of that light typically stays on the chip, trapped in optical wires, and is difficult to transmit to the outside world in an efficient manner.
If a lot of light could be rapidly and precisely beamed off the chip, free from the confines of the wiring, it could open the door to higher-resolution displays, smaller Lidar systems, more precise 3D printers, or larger-scale quantum computers.
Now, researchers from MIT and elsewhere have developed a new class ...
(Santa Barbara, Calif.) — For decades, astronomers have used distant supernovae as cosmic lighthouses to test fundamental physics and to measure the universe. For Joseph Farah, a fifth-year graduate student at UC Santa Barbara, one particular supernova began to signal something never seen before: a “chirp.”
In a groundbreaking paper accepted to the journal Nature, Farah and a team of international researchers, including his advisor Andy Howell, who leads the supernova group at Las Cumbres Observatory (LCO), announce the discovery of a superluminous supernova (SN 2024afav) whose erratic behavior has confirmed a long-standing theory ...
Coral reefs are being hit hard by the climate crisis, and timely interventions for their survival are a top priority. The Global Coral Tech Transfer Project enables SECORE International and the Australian Institute of Marine Science (AIMS) to implement the latest scientifically developed coral breeding techniques on a large scale across regions. The practical implementation of the project is carried out jointly and in close cooperation with Dominican Republic-based partner FUNDEMAR, combining Australian technology, Caribbean coral breeding science, and in-depth experience in implementing restoration efforts successfully. ...
In the rapidly evolving landscape of automotive technology, vision sensing has emerged as a crucial component for intelligent driving systems. A recent article published in Engineering, titled “Vision Sensing for Intelligent Driving: Technical Challenges and Innovative Solutions,” offers an in-depth analysis of the current state of vision sensing technology and explores potential solutions to enhance its performance.
The authors, Xinle Gong from the School of Mechanical Engineering at Beijing ...
LAWRENCE — To be an excellent three-point shooter, you can be Stephen Curry. Or failing that, you can rely on sound biomechanics in the preparatory phase of a shooting motion from behind the arc.
New research from the University of Kansas has found that proper elbow positioning — along with greater flexion in the hips, knees and ankles prior to initiating the shooting motion — is one of the key determinants of successful long-range shooting efficiency. That science will now be used in an attempt to set a new world record for most consecutive made three-point shots.
Researchers at KU’s Jayhawk Athletic Performance Laboratory, ...
AI chatbots are standardizing how people speak, write, and think. If this homogenization continues unchecked, it risks reducing humanity’s collective wisdom and ability to adapt, computer scientists and psychologists argue in an opinion paper publishing March 11 in the Cell Press journal Trends in Cognitive Sciences. They say that AI developers should incorporate more real-world diversity into large language model (LLM) training ...
Severe COVID-19 and influenza infections prime the lungs for cancer and can accelerate the disease’s development, but vaccination heads off those harmful effects, new research from UVA Health’s Beirne B. Carter Center for Immunology Research and UVA Comprehensive Cancer Center indicates.
UVA School of Medicine researcher Jie Sun, PhD, and colleagues found that serious viral infections “reprogrammed” immune cells in the lungs to facilitate the growth of cancer tumors months or even years later. Based on their findings, the scientists are urging doctors to closely monitor patients who have recovered from severe ...
About The Study: In this cross-sectional study, wildfire exposure and its socioeconomic consequences were associated with graded increases in psychological distress extending beyond the burn zone. These findings highlight the importance of integrating mental health care, housing stability, and economic recovery as central pillars of disaster response and climate resilience strategies.
Corresponding Author: To contact the corresponding author, Ruben Juarez, PhD, email rubenj@hawaii.edu.
To access the embargoed study: Visit our For The Media ...
About The Study: The findings of this cohort study suggest that glucagon-like peptide–1 receptor agonist (GLP-1 RA) use was associated with significant reduction in all-cause mortality among patients with cancer with brain metastases and type 2 diabetes, with generally consistent association across subgroups. These results build upon existing evidence that GLP-1 receptor activation modulates pathways relevant to neuro-oncologic health, including attenuation of neuroinflammation, preservation of blood–brain barrier integrity, and reduction of oxidative stress and mitochondrial dysfunction.
Corresponding ...
